Significant associations were found between Syk expression and ovarian cancer subtype (Syk-c: χ2 = 46.443, df = 5, P = 7.3773E−9; Syk-n: χ2 = 26.744, df = 5, P = 0.000064), stage (only Syk-c: χ2 = 11.520, df = 3, P = 0.009), and tumour response to taxane-containing chemotherapy (only Syk-n: χ2 = 7.078, df = 1, P = 0.008). This evidence concerns the gene SYK and ovarian cancer.